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The biotransformation of ß-estradiol (1,3,5-estratriene-3,17,ß-diols) by Bacillus subtillus resulted in four 
metabolites which were (1) 3,5-estratriene-3-ol–17–one, (2) 1,3,5-estratriene-3,16,17-triol, (3) 1,3,5,7-
estratetra-ene-3-ol-17-one and (4) 1,3,5,6, estratetra-ene-3-ol-17-one. The structures were elucidated on 
the basis of spectroscopic techniques. Compound 3 showed good inhibitory activity against 
lipoxygenase enzyme. 
 






Biotransformation is increasingly exploited as a useful 
and often unique reaction step in the semi synthesis of 
pharmaceuticals or for structural modification of complex 
natural compounds (Jovetic et al., 1998). In a chemical 
synthesis, a variety of catalysts and protecting group are 
needed for well defined chemical transformation. An 
alternative way of structural modification of substrate is 
the use of some bio-cataylst (isolated enzymes, cell 
extract, plants and animals, whole cell of bacteria, yeast, 
micro algae and fungi) under mild conditions collectively 
called biotransformation. The transformation of substrate 
that occurred by this pathway are regio-and stereo-
selective or sometimes novel (Javid et al., 2010). ß-
Estradiol was isolated from chloroform soluble fraction of 
Sonchus eruca belonging to the family of asteraceae. 
The asteraceae or sunflower family (formerly composite, 
also known as the Aster family) is a family of dicoty-
ledonous flowering plants. It is the largest family of 
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23000 species, distributed in three sub-families and 17 
tribes. It is also the largest plant family in Pakistan, repre- 
sented by over 650 species distributed in 15 tribes 
(Carvalho et al., 2006). ß-estradiol is the most potent and 
naturally occurring estrogen in human beings followed by 
estrone and estriol (Bulent and Inci, 2002). 
Estradiol is one of the most abundant and important 
estrogens occurring in animals and man (Jan et al., 
2002). Estrogen plays a central role in the development 
and maintenance of the female reproductive organs, 
mammary glands and other sexual characteristics. The 
decreased production of estrogen has been linked to a 
series of postmenopausal pathologies, such as mood 
alterations, sleeplessness, hot flushes, sweats and 
sexual dysfunction (Muhammad et al., 2005).  
In continuation of the work with microbial transfor-
mation of steroid, incubation of compound 1 with Bacillus 
subtilus and Aspergillus niger resulted in the formation of 
four metabolites (Scheme 1) which were reported for the 
first time via B. substillus. Metabolite 2 underwent 
reduction at C-19, metabolite 3 underwent hydroxylation 
at C-18, metabolite 4 underwent reduction at C-19 and 
also exhibited dehy-drogenation at C-7 and C-8, and 
metabolite 5 underwent reduction at C-19 and also exhibited  




ehydrogenation  at C-6 and C-7. 
 
 




The plant Sonchus eruca was collected at Parachinar Kurram 
agency, N.W.F.P Pakistan, in July 2008 and was identified by 
plants taxonomist. The voucher specimen has been deposited in 
the herbarium of the Botany Department of Kohat University of 
Science and Technology Kohat (KUST). The whole plant was air-
dried for 10 days and milled into powder with an electrical grinder 
and finally, was stored in airtight bottles before analysis. 
 
 
General experimental procedure 
 
The electron ionization mass spectra (EI-MS) were measured on a 
Varian MAT 311 A mass spectrometer. The HR-EI-MS spectra were 
recorded on Joel JMS-600H mass spectrometer. The 1H NMR 
spectra ( in ppm, J in Hz) were obtained in deuterated solvent 
(CDCl3) at 400 MHz on Bruker Avance-400 NMR spectrometer, 
while 13C NMR spectra were recorded in CDCl3 on the same instru-
ment at 100 MHz. The FTIR were recorded on Shimadzu FTIR-
8900 spectrophotometer. UV spectra were recorded on advance 
UV spectrophotometer. Optical rotation measurement was perfor-
med on Jasco DIP-360 digital polarimeter. Melting point was taken 
on Buchi 535 apparatus. The metabolites were purified on column 
chromatography on silica gel. The purity of sample was checked on 
precoated TLC plates (Si 60, PF 254, 20 × 20, 0.25 mm, E. Merck).  
 
 
Preparation of media 
 
The medium for B. subtillus (NRRL-68751) was prepared by mixing 
the following reagents and distilled water (2 L): glucose (10 g), 
peptone (2 g), yeast extract (10 g) and sucrose (4 g). The media for 
A. niger (NRRL-68751) was prepared by mixing glucose (20 g), 
peptone (10 g), KH2PO4 (10 g), yeast extract (10 g), glycerol (10 
ml) and NaCl (10 g) in distilled water (2 L) and the pH was 
maintained at 5.6. 
 
 
Culture and fermentation procedure 
 
The following procedure was used for both B. subtllus and A. niger. 
Two days old spores of the bacteria were aseptically transferred 
into the broth medium flask containing 100 ml of freshly prepared 
and auto claved medium. The seed flask thus obtained was 
incubated on a shaker table at 30°C for two days. The two days old 
broth culture from the 100 ml seed flask was inoculated into 20 
media flask (250 ml) containing 100 ml of the medium and fermen-
tation was continued for further 24 h. Compound 1 (700 mg) was 
diluted with acetone (10 ml) and the resulting solution was evenly 
distributed among 20 conical flask having the shake culture and the 
fermentation was continued for 10 days for B. subtillus and for 12 
days for A. niger. The mycelia were filtered, washed with ethyl 
acetate and the broth thus obtained was extracted with ethyl 
acetate. The extract was dried over anhydrous sodium sulphate 
and was concentrated in vacuum to obtain gums. These were 
adsorbed on equal quantity of Silicon (Si) gel and were eluted with 
various solvents, gradients of petroleum ether, EtoAc and MeOH. 
The obtained compounds 2, 3, 4 and 5 had 14.7, 6.2, 20.2 and 
10.2% yield, respectively. The remaining compound (compound 1) 
was recovered unchanged. The yield of compounds 2 and 3 from A. 





Assay of lipoxygenase inhibition 
 
Lipoxygenase inhibiting activity was conveniently measured by 
slightly modifying the spectrometric method developed by Tappel 
(Tappel, 1962). Lipoxygenase (1.13.11.12) type I-band linoleic acid 
was purchased from Sigma (St. Louis, MO, USA). 160 µl of 0.1 mM 
sodium phosphate buffer (pH 7.0), 10 µl of the test-compound 
solution and 20 µl of lipoxygenase solution were mixed and 
incubated at 25°C for 5 min. The reaction was then initiated with the 
addition of 10 µl of linoleic acid (substrate) solution, and resulted in 
the formation of (9Z, 11E)-(13S)-13-hydroperoxyoctadeca-9, 11-die-
noate, the change in absorbance was read after 10 min at a 
wavelength of 234 nm. The test compound and control were 
dissolved in 50% EtOH. All reactions were performed in triplicate. 
The IC50 values were then calculated using the EZ-fit enzyme 
kinetics program (Perrella Scientific Inc., Amherst, USA). 
 
 
RESULTS AND DISCUSSION 
 
The fermentation of compound 1 with B. subtillus for 10 
days yielded the reductive metabolite 2. The molecular 
formula of compound 2 determined from HR-EI-MS was 
found to be C18H22O2 and showed M
+ at m/z 270.3706. 
The IR spectrum of compound 2 showed kenotic and 
hydroxyl absorption at 1720 and 3335 cm-1, respectively. 
The 13C NMR data of compound 2 was the same to the 
authentic sample except for the absorption at C-17. The 
unusual 13C NMR spectrum (100MHz, C5D5N) has absor-
ption at δ 219.6 for C-17 instead of absorption at δ 81.22 
for the authentic sample (Table 2), due to the presence of 
five member ring that caused angle strain. 1H NMR 
further confirmed this by the disappearance of absorption 
at  3.92 (J = 8 Hz, H-17) in compound 2 as absent in the 
authentic sample (Table1). 
The molecular formula of compound 3 determined from 
HR-EI-MS was found to be C18H22O3, and showed M
+ at 
m/z 288.3858. The NMR data of compound 3 was also 
the same to the authentic sample but only was different in 
1H NMR absorption at H-17 and H-16 in 1H NMR 
spectrum and C-17 and C-16 in the 13C NMR spectrum. 
The 1H NMR spectrum of compound 3 had an overlapped 
peak at 4.68 (H-17) instead of a peak at 3.92 (J = 8 Hz, 
H-17) in the authentic sample (Table 1). This assumption 
was further confirmed with 13C NMR spectrum having 
absorption at δ 82.30 for C-16 of methyne, instead of 
absorption at δ 30.90 for C-16 methylene (Table 2). Fur-
thermore, no interaction was observed in NOE between 
H-16 and H-17, which confirmed that H-16 and H-17 had 
different stereochemistry; H-16 was ß while H-17 was . 
In NOE spectrum, the position of 16-OH was further 
confirmed through COSY interaction of H-16 with H-17 
(Horeau and Kagan, 1964), and was used to assign the 
stereochemistry of the newly formed hydroxyl group at 
position-17 of the compound 3. 
The molecular formula of compound 4 determined from 
HR-EI-MS was found to be C18H20O2, and showed M
+ at 
m/z 268.3548. The IR spectrum of compound 4 showed 
olefinic, ketonic and hydroxyl absorption at 1604, 1665 
and 3335 cm-1,  respectively.  The  1H  NMR  spectrum  of  




Table 1. 1H NMR assignments of compound (1) and its metabolites 2 to 5. 
 
Proton 1 2 3 4 5 
H-1 7.09 d (12.6) 7.06 d (12.6) 7.27 d (12.6) 7.11 d (12.6) 7.04 d (12.6) 
H-2 7.00 dd (10.4, 6.6) 6.99 dd (10.4, 6.6) 6.58 dd (10.4, 6.6) 7.00 dd (10.4, 6.6) 6.78 dd (10.4, 6.6) 
3-OH 8.70s 8.71s 8.70 s 8.69 s 8.69 s 
H-4 6.99 dd (16.2, 4.3) 7.00 dd (16.2, 4. 3) 6.98 dd (16.2, 4. 3) 7.01 dd (16.2, 4. 3) 6.72 dd (16.2, 4. 3) 
H-5 - - - - - 
H-6 2.81t (2.5, 6.2) 2.82 t (2.5, 6.2) 2.85 t (2.5, 6.2) 3.42 t (2.5, 6.2) 5.56 d 
H-7 1.26, 1.78 1.27, 1.79m 1.40, 1.66 m 5.41 m 5.48 dd 
H-8 1.29 m 1.30 m 1.43 m - 3.38 m 
H-9 2.09 m 2.08 m 2.08 m 3.43 t 2.10 m 
H-10 - - - -  
H-11 2.17, 1.29 m 2.29, 1.37m 2.24, 1.30 m 2.21, 1.63 m 2.23, 1.28 m 
H-12 1.12, 1.73d (11.7) 1.29, 1.80 d (11.7) 1.46, 1.66 d (11.7) 1.10, 1.64 d (11.7) 1.16, 1.80 d (11.7) 
H-13 - - - - - 
H-14 1.79 m 1.44 m 1.50 m 2.43 m 1.52 m 
H-15 1.79 m 1.79 m 1.66, 1.08 m 1.64, 1.08 m 1.58, 1.28 m 
H-16 1.78, 1.32 m 1.93, 1.43t (2.2, 25) 4.03 m 1.94,173 t 1.84, 1.30 t (2.2, 25) 
16-OH - - 4.66 s - - 
H-17 3.89 t (17.1, 8.5) - 4.05 d (20.08) - - 
17-OH 3.92 s - 4.68 s - - 
H-18 0.98 0.80 1.06 0.70 0.86 
 




Table 2. 13C NMR chemical shifts and multiplicities of metabolites 1 to 5. 
 
Carban 1 2 3 4 5 
C-1 126.8 (CH) 126.9 (CH) 126.8 (CH) 128.6 (CH) 128.4 (CH) 
C-2 113.8 (CH) 113.9 (CH) 113.9 (CH) 115.0 (CH) 115.0 (CH) 
C-3 156.6 (Q) 156.8(Q) 156.7 (Q) 157.0 (Q) 157.3 (Q) 
C-4 116.2 (CH) 116.3 (CH) 116.3 (CH) 116.0 (CH) 116.0 (CH) 
C-5 138.1 (Q) 138.0 (Q) 138.1 (Q) 136.5 (Q) 135.9 (Q) 
C-6 29.9 (CH2) 29.8 (CH2) 29.7 (CH2) 30.1 (CH2) 126.9 (CH) 
C-7 26.8 (CH2) 26.3 (CH2) 26.3 (CH2) 122.9 (CH) 116.3 (CH) 
C-8 39.4 (CH) 38.7(CH) 38.8 (CH) 123.2 (Q) 40.4 (CH) 
C-9 43.7 (CH) 44.3 (CH) 45.0 (CH) 49.5 (CH) 49.5 (CH) 
C-10 131.4 (Q) 130.8 (Q) 130.9 (Q) 129.3 (Q) 129.2 (Q) 
C-11 27.6 ( CH2) 26.8 (CH2) 26.9 (CH2) 30.1 (CH2) 30.1 (CH2) 
C-12 37.4 (CH2) 35.9 (CH2) 36.9 (CH2) 35.5 (CH2) 36.7 (CH2) 
C-13 43.7 (Q) 44.3 (Q) 44.5 (Q) 49.5 (Q) 49.6 (Q) 
C-14 50.2 (CH) 50.3 (CH) 50.4 (CH) 50.7(CH) 50.7 (CH) 
C-15 23.4 (CH2) 21.6 (CH2) 22.6 (CH2) 19.9 (CH2) 20.9 (CH2) 
C-16 30.9 (CH2) 32.1 (CH2) 82.3 (CH) 32.7 (CH2) 32.7 (CH2) 
C-17 81.2 (CH) 219.0 (C=O) 82.2 (CH) 218.1 (C=O) 220.2 (C=O) 
C-18 11.6 (CH3) 13.8 (CH3) 12.2 (CH3) 13.7 (CH3) 13.6 (CH3) 
 




compound 4 was similar to that of compound 2; the only 
difference was the olefinic group at C-7 and C-8 position. 
The 1H NMR data of compound 4 had only difference in 
absorption at δ 5.41(m) H-7 for H-7 methine instead of at 
δ1.27 for H-7 methyne (Table 1). This assumption was 
further   confirmed   through   13C NMR  spectrum  with  a 




































































signal for C-7 at δ 122.95 (CH) instead of a signal at  δ 
26.88(CH2), while C-8 was at  δ 123.25(q) instead of at δ 
39.40(CH) (Table 2). Further, the position of the double 
bond was confirmed by the HMBC interaction of the 
signal of H-6 at  5.41 (overlap), with C-8, C-9 and C-14, 
respectively. 
The molecular formula of compound 5 determined from 
HR-EI-MS was found to be C18H20O2, and showed M
+ at 
m/z 268.3467. The IR spectrum of compound 5 showed 
olefinic, ketonic and hydroxyl absorption at 1607, 1667 
and 3338 cm-1, respectively. The 1H NMR spectrum of 
compound 5 was similar to that of compound 4. The only 
difference was for the olefinic group which shifted from C-
7 and C-8 in compound 4 to C-6 and C-7 positions in 
compound 5. The 1H NMR spectrum of compound 5 
showed absorption peak for H-6 at δ 5.56(CH) instead  of 
at δ 3.42(CH2) (Table 1). The assumption was further 
confirmed through 13C-NMR spectrum with a signal for C-
6 at δ 126.93 (CH), instead of at δ 30.17(CH2) in 
compound 4 (Table 2). Further, the position of the double 
bond between C-6 and C-7 was confirmed by the HMBC 
interaction experiment. 
Compounds 1 to 5 were screened for the inhibition of 
lipoxygenase enzyme. Lipoxygenase constitute a family 
of non-haem iron containing dioxygenases that are widely 
distributed in animals and plants. In mammalian cells, 
these are key enzymes in the biosynthesis of variety of 





Table 3. Inhibitory activity (IC50 (µM)) of compounds 1 to 5 
against lipoxygenase enzyme. 
 










acids (HETEs), leukotrienes, lipoxins and hepaxylines. 
Lipoxygenases are therefore, regarded as an attractive 
target for the rational drug design and discovery of 
mechanism-based inhibitors of treatment of variety of 
disorders such as bronchial asthma, inflammation, cancer 
and autoimmune diseases ( Lili  et al., 2004). The IC50 
values of metabolites 1 to 5 are shown in Table 3, along 
with the positive control of lipoxygenase (Baicalcin). The 
biological screenings revealed that, metabolite 3 had 
more inhibitory potential against the lipoxygenase enzyme 
than -estradiol, while metabolites 4 and 5 also had 
moderate inhibitory activity against the lipoxygenase 
enzyme (Table 3). Similarly, compound 1 showed non- 
significant potential followed by compound 2 which was 
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